期刊文献+

老年2型糖尿病患者子女血浆纤溶酶原激活物抑制物1活性与胰岛素抵抗的关系

Relationship between the activity of plasma plasminogen activator inhibitor type-1 and the insulin resistance in the children of the elderly with type 2 diabetes
下载PDF
导出
摘要 目的:检测老年2型糖尿病患者子女血浆纤溶酶原激活物抑制物-1(plasmaplasminogenactivatorinhibitortype-1,PAI-1)活性,分析它们与血脂、血糖、体质量指数、腰臀比、胰岛素抵抗之间关系。方法:选择2002-01/12河北省人民医院健康查体者54例为对照组,男26例,女28例。选择同期在本院门诊就诊及住院2型糖尿病患者的子女92例为子女组,男44例,女48例。测定两组对象血脂、血糖,采用发色底物法测PAI-1活性,用稳态模型胰岛素抵抗指数(HOMA-IR)评估胰岛素抵抗。结果:子女组血浆PAI-1活性犤(0.73±0.30)kAU/L犦显著高于对照组犤(0.51±0.19)kAU/L犦(P<0.05)。子女组HOMA-IR明显高于对照组(P<0.01)。PAI-1活性与Ln空腹胰岛素,三酰甘油呈正相关(r=0.38,0.46,P<0.01);PAI-1活性与InHOMA-IR呈正相关(r=0.14,P<0.05)。结论:老年2型糖尿病患者子女血浆PAI-1活性升高,且PAI-1活性与胰岛素抵抗密切相关;PAI-1在2型糖尿病的发生发展中起着重要作用。 AIM:To measure the activity of plasma plasminogen activator inhibitor type-1(PAI-1) in the children of the elderly with type 2 diabetes mellitus(DM) and analyze the relation with blood lipid,blood sugar,body mass index(BMI),waist-to-hip ratio(WHR),insulin resistance(IR). METHODS:Fifty-four people for health examination in Hebei Provincial People's Hospital from January to December 2002 were selected as controls,including 26 males and 28 females.Meanwhile,92 children of the type 2 DM inpatients were selected as children group,including 44 males and 48 females.Blood lipid and blood sugar were measured,fasting plasma PAI-1 activity was measured by the synthetic chromogenic method using a colorimetric assay,and homeostasis model assessment insulin resistance(HOMA-IR) was used for analysis of IR. RESULTS:The activity of plasma PAI-1 was significantly higher in the children group[(0.73±0.30)kAU/L] than the control group[(0.51 ±0.19) kAU/L](P< 0.05).There was positively linear correlation between plasma PAI-1 activity and fasting insulin levels(r=0.38,P=0.001), triglycerides TG(r=0.46,P< 0.001), HOMA-IR (r=0.14,P=0.03). CONCLUSION:Serum PAI-1 activity increases in the children of the elderly with type 2 DM,and it is closely correlated with IR.PAI-1 plays an important role in the occurrence and development of type 2 DM.
出处 《中国临床康复》 CSCD 北大核心 2005年第7期52-53,共2页 Chinese Journal of Clinical Rehabilitation
  • 相关文献

参考文献6

  • 1Eliasson M, Asplund K, Evrin PE, et al. Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: the Northern Sweden MONICA Study, Metabolism 1994; 43 (12): 1579 - 86.
  • 2Gurlek A, Bayraktar M, Kirazli S. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels. Diabetes Care 2000; 23 ( 1 ): 88 - 92.
  • 3Vuorinen-Markkola H, Puhakainen 1, Yki-Jarvinen H. No evidence for short-term regulation of plasminogen activator inhibitor activity by insulin in man. Thromb Haemost 1992; 67 ( 1 ): 117 - 20.
  • 4Festa A, D' Agostino R Jr, Mykkanen L, et al. Relative contribution of insulin and its precursors to fibfinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS) Arterioscler Thromb Vasc Biol 1999; 19(3): 562- 8.
  • 5Nordt TK, Sawa H, Fujii S, et al. Induction of plasminogen activator inhibitor type- 1 ( PAI- 1 ) by proinsulin and insulin in vivo. Circulation 1995; 91 (3): 764 - 70.
  • 6Samad F, Loskutoff DJ. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol Med 1996; 2 (5): 568 - 82.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部